27 JUNE 2019
ImmuPharma PLC
("ImmuPharma" or the "Company")
2019 ANNUAL GENERAL MEETING - ALL RESOLUTIONS PASSED
ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, held its AGM earlier today and is pleased to announce that all resolutions were duly passed.
-Ends-
For further information please contact:
ImmuPharma PLC (www.immupharma.com) Tim McCarthy, Chairman |
+ 44 (0) 207 152 4080 |
Dimitri Dimitriou, Chief Executive Officer |
|
Lisa Baderoon, Head of Investor Relations |
+ 44 (0) 7721 413496 |
SPARK Advisory Partners Limited (NOMAD) Neil Baldwin Vassil Kirtchev Stanford Capital Partners (Joint Broker) Patrick Claridge, John Howes SI Capital (Joint Broker) Nick Emerson |
+44 (0) 203 368 8974 +44 (0) 203 815 8880 +44 (0) 1483 413500 |
|
|
|
|
|
|
|
|
|
|
|
|
